Andrew Hopkins, as the founder and CEO of Exscientia, leads a global pharmatech company at the forefront of using AI for drug discovery. Exscientia focuses on encoding, automating, and transforming every stage of the drug design and development process by blending AI with experimental innovation. Under Hopkins' leadership, the company has achieved significant milestones, including delivering the f...